Collagen decline is one of the most well-documented aspects of skin ageing. Here is what the research says about the pathways studied for skin health and collagen biology, and what therapeutic access looks like in Australia.
This article is for general educational purposes only and does not constitute medical advice. Doctor-led health protocols in Australia require assessment and prescription from an AHPRA-registered medical practitioner. Therapeutic use of compounded medicines is distinct from over-the-counter cosmetic products. Always consult a qualified doctor before making any decisions about your health.
Skin ageing is one of the most visible manifestations of biological ageing, and collagen decline is one of the most well-documented mechanisms behind it. Collagen, the primary structural protein of the skin, is produced at declining rates from the mid-20s onwards, with visible effects accumulating over subsequent decades. Scientific research into compounds that can interact with collagen synthesis and skin repair pathways has been ongoing for decades, and several research areas have attracted genuine scientific interest.
This guide covers the biology of skin ageing, which research areas have been most studied in skin and collagen contexts, what the evidence actually shows, and the important distinction between therapeutic use and over-the-counter cosmetic products.
Skin ageing has both intrinsic and extrinsic components. Intrinsic ageing is driven by biological processes that affect all tissues over time, including declining collagen production, reduced fibroblast activity, diminishing growth factor signalling, and accumulating cellular damage. Extrinsic ageing is driven by environmental factors, most significantly ultraviolet radiation exposure, which accelerates many of the same processes.
Collagen is the primary structural protein of the dermis, providing tensile strength, elasticity, and the architectural scaffold that gives skin its structure. Collagen production by fibroblasts declines progressively with age, while existing collagen is degraded by enzymes whose activity is accelerated by UV exposure and inflammation. The result is thinner, less elastic skin with reduced capacity to repair itself efficiently.
Research into compounds for skin health centres on those that may interact with fibroblast activity, collagen synthesis pathways, skin repair mechanisms, and the inflammatory processes that accelerate collagen degradation.
Scientific research into skin health and collagen biology covers a range of pathways. The specific compounds appropriate for any individual are determined solely by a prescribing doctor following clinical assessment - not by the information on this page.
Naturally occurring copper peptides are present in human plasma at concentrations that decline with age. Research has examined the interaction of these compounds with fibroblast activity, collagen synthesis, wound healing, skin repair, and gene expression relevant to skin biology. This area has one of the more developed research bases for skin-relevant applications, with some research conducted in human contexts. These compounds also appear in cosmetic skincare formulations, though the concentrations and delivery methods in therapeutic contexts differ significantly from cosmetic products.
Research primarily focused on musculoskeletal and gastrointestinal tissue repair has relevance to skin biology through the broader repair mechanisms it examines. The growth factor signalling and tissue repair environment pathways studied in musculoskeletal contexts are also relevant to skin as one of many tissues that depend on these processes.
Growth hormone plays a role in skin thickness, collagen synthesis, and skin repair capacity. Research has examined the downstream effects of growth hormone pathway interaction on skin biology as one component of the broader influence on tissue repair and body composition. Growth hormone declines with age, contributing to age-related skin changes alongside collagen decline.
Chronic inflammation, sometimes called inflammaging, accelerates collagen degradation and skin ageing. Research into compounds studied for their interaction with inflammatory pathways is relevant to skin health indirectly, as reducing chronic low-grade inflammation is one area researchers have studied in the context of supporting healthier skin ageing biology.
This distinction matters significantly. Some compounds studied in skin biology research also appear in over-the-counter cosmetic skincare products. These products are regulated as cosmetics, not medicines, and the concentrations and delivery methods are different from therapeutic use.
When compounds are accessed through a licensed compounding pharmacy via a doctor's prescription, the concentration, delivery form, and administration route are determined by a prescribing doctor based on clinical assessment rather than cosmetic product marketing. The skin barrier limits how much of any topically applied compound can penetrate to the dermis where collagen is produced. Systemic delivery methods used in therapeutic contexts interact with different biological processes than topical cosmetic applications.
Why delivery method matters in skin research: Research examining systemic delivery of skin-relevant compounds is examining a different set of potential biological interactions to research on topical cosmetic applications. The concentrations, delivery routes, and biological accessibility differ substantially. A prescribing doctor determines which approach and delivery method is appropriate for any individual based on clinical assessment.
Research into copper peptide pathways relevant to skin biology has examined interaction with fibroblast activity, collagen and elastin synthesis pathways, wound healing processes, and gene expression relevant to skin biology. Some of this research has been conducted in human contexts. For other research areas relevant to skin health, such as growth hormone and tissue repair pathways, the skin health applications are downstream effects of compounds studied primarily for other purposes, and whether they are relevant for any individual depends on the full clinical picture.
Where clinically appropriate, individuals may undergo an assessment by an AHPRA-registered medical practitioner. Skin health may be addressed as a primary focus of an assessment or as one component of a broader discussion of health and biology. Any decision regarding treatment is made solely by the prescribing doctor following assessment of the individual's medical history and clinical circumstances. There is no cost to request an assessment, and no obligation to proceed.
Start with a free assessment. A doctor reviews your health picture and determines whether a protocol is clinically appropriate for your specific situation. No cost until you choose to proceed.